Developer docs
API playgroundTry for free, no card

Search company profiles

SeroRepair

Full company profile

uuid00shrrk

Namestring
SeroRepair
Legal namestring
SeroRepair
Websiteurl
serorepair.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

SeroRepair is a privately-held veterinary biotechnology company headquartered in Kaysville, Utah (590 N. Kays Drive, Unit 110), that develops biologic products aimed at simplifying ocular care for veterinary clinics, patients, and pet owners. The company's sole commercial product, SeroLube, is a frozen, donor-derived, blood plasma-based eye serum manufactured from bovine plasma using a controlled process designed for consistency and safety. Unlike conventional autologous eye serum therapy — which requires drawing blood from the patient, processing the sample in-clinic, and decanting into dropper bottles over a 40-50 minute workflow — SeroLube is delivered as a sterile, ready-to-dispense dropper that can be stored in the clinic freezer and dispensed to the patient immediately. The product is positioned for use in corneal ulcers, indolent ulcers, corneal trauma, KCS/dry eye support, post-operative ocular care, and inflammatory ocular surface conditions, and the company frames it as supporting a Fear Free veterinary care approach by eliminating patient blood draws.

The company's business model is a one-time product sale of SeroLube, distributed exclusively through veterinary pharmaceutical and supply distributors including MWI Animal Health, Midwest Veterinary Supply, Covetrus, Vetcove, PennVet, and Veterinary Health Associates (VHA). Pricing is not publicly disclosed, and orders are routed through distributor platforms and a direct order pathway on the company's website. The primary customer segment is veterinary professionals and clinics; pet and equine owners constitute a secondary end-user audience. Marketing is concentrated in digital content (website, webinars, clinical handouts, research summaries) and distributor-led promotion, with no disclosed field sales force. The company provides no public financial data — no revenue, funding history, headcount, management team, ownership structure, or regulatory certifications are disclosed in available source material, and there is no indication of patents or trademarks on file. Company website copyright is dated 2026, and the company uses "SeroLube" as a trade name.

Short descriptiontext

SeroRepair is a privately-held veterinary biotechnology company that develops SeroLube, a frozen donor-derived bovine plasma eye serum sold through veterinary distributors to clinics for treating animal ocular surface conditions.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersKaysville, United States
HQ citystring
Kaysville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
veterinary eye serum, plasma-based therapy, animal ocular care, veterinary biologics, ophthalmic treatment products
Industry1 code
PRIMARYHLAMAEAN
Medicated Feed Additives & Premixes (Veterinary Pharmaceuticals)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
NAICS code1 code
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code2 codes
  • Biological Products, (No Disgnostic Substances)2836
  • Pharmaceutical Preparations2834
Product category
Veterinary Biologics
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1SeroLube Product Sales
TypeOne Time License
Description

Sale of frozen plasma eye serum products to veterinary clinics and pet owners through distributor partnerships.

serorepair.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

SeroRepair manufactures and sells SeroLube, a frozen, donor-derived, blood plasma-based eye serum for veterinary use. The product is made from bovine plasma using a controlled manufacturing process and is packaged in sterile, ready-to-dispense dropper bottles that veterinary clinics can store in a freezer and dispense immediately to patients. It eliminates the traditional 40-50 minute in-clinic blood draw and serum processing workflow required for conventional autologous eye serum therapy.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Replaces 40-50 minute eye appointment process with ready-to-use dropper dispensing
Product overview1 text field

SeroRepair is a veterinary-focused biologic company that develops practical solutions to simplify eye care for clinics, patients, and pet owners. Their product portfolio consists of a single core offering: SeroLube, a frozen, donor-derived blood plasma-based eye serum. Unlike traditional eye serum therapy that requires in-clinic blood drawing and processing, SeroLube comes ready-to-dispense in sterile dropper bottles that can be stored in the clinic freezer and sent home with patients immediately. The product is made from bovine (cow) plasma using a controlled process designed for consistency and safety.

Product and service1 record
1SeroLube
CategoryVeterinary Biologics
Description

A frozen, donor-derived, blood plasma-based eye serum for veterinary use, manufactured from bovine plasma via a controlled process. Packaged in sterile, ready-to-dispense dropper bottles that can be stored in a clinic freezer and sent home with the patient immediately. Provides serum-based biologic support for animal eyes, including tear-like proteins, growth factors, and anti-inflammatory mediators, to support epithelial health, surface hydration, and corneal comfort in conditions such as corneal ulcers, indolent ulcers, corneal trauma, KCS/dry eye, post-operative care, and inflammatory ocular surface conditions. Intended for use under the direction of a veterinarian as part of an appropriate treatment plan.

Partnership6 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Major veterinary distributor offering SeroLube through their platform for ordering and distribution to veterinary clinics.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Regional veterinary supply distributor providing access to SeroLube for veterinary practices in their distribution network.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Global animal health company distributing SeroLube as part of their veterinary pharmaceutical and supply portfolio.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Veterinary marketplace platform enabling veterinary practices to order SeroLube from multiple distributors.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

University-affiliated veterinary supplier distributing SeroLube, potentially serving academic veterinary hospitals.

6Veterinary Health Associates (VHA)
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Veterinary buying group providing member clinics access to SeroLube at negotiated pricing through group purchasing.

serorepair.com
Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Zoetis is the world's largest animal health company with a broad portfolio of companion animal pharmaceuticals and biologics. It is a broad incumbent because it sells competing ocular therapeutics alongside vaccines, parasiticides, and other biologics through the same major veterinary distributors SeroRepair relies on.

TypeDirect peer
Description

Aventix markets Optixcare and related ocular lubricants and tear-stimulating drops for companion animals. It is a direct peer because both companies provide ready-to-use ocular surface support products sold through veterinary channels as alternatives to in-clinic compounded or processed preparations.

TypeBroad incumbent
Description

Ceva is a global animal health company with a sizable companion animal portfolio including ophthalmology products. It is a broad incumbent because it competes for veterinary shelf space and prescribing across multiple species and therapeutic categories rather than specializing in ocular biologics.

TypeDirect peer
Description

Sentrx develops and markets cross-linked hyaluronic acid-based eye care products (bioHAnce) for veterinary use. It is a direct peer because both companies sell biologic-style ocular surface therapeutics through veterinary distribution channels to clinics treating companion animal eye conditions.

TypeBroad incumbent
Description

Dechra is a global specialty veterinary pharmaceuticals company with a meaningful ophthalmology portfolio and broad companion animal distribution. It is a broad incumbent because it competes for the same veterinary prescribing decisions but operates across many therapeutic categories beyond ocular biologics.

TypeBroad incumbent
Description

Virbac is a global animal health company with a dedicated companion animal and ophthalmology presence. It is a broad incumbent because it offers competing ocular therapeutics as part of a broader portfolio and reaches US veterinary clinics through the same major distribution partners as SeroRepair.

TypeDirect peer
Description

Dômes Pharma's TVM division is a European veterinary ophthalmology specialist with a broad line of ocular therapeutics. It is a direct peer because it competes in the same veterinary eye care prescribing space and addresses similar ocular surface conditions in companion animals.

8I-MED Animal Health
TypeDirect peer
Description

I-MED Animal Health is a specialty veterinary ophthalmology company that sells diagnostic and therapeutic eye care products to veterinarians. It is a direct peer because both companies focus exclusively on veterinary ocular therapeutics sold through veterinary professional channels.

TypeBroad incumbent
Description

Vetoquinol is an established global animal health pharmaceutical company selling through veterinary distribution. It is a broad incumbent because it competes in veterinary ocular therapeutics as part of a broader species and therapeutic portfolio served by the same veterinary wholesalers that carry SeroLube.

TypeBroad incumbent
Description

Elanco is a top-tier global animal health company whose Remend corneal repair gel is a directly competing veterinary ocular surface product. It is a broad incumbent because it sells the competing eye care product alongside a much larger pharmaceutical and biologic portfolio across companion animal and livestock markets.

Market position
Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat2 records

Each record includes

Type, Details

Key risks1 record

Each record includes

Headline, Details, Source

Key highlights1 record

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SeroRepair

Veterinary Biologicsserorepair.com

SeroRepair is a privately-held veterinary biotechnology company that develops SeroLube, a frozen donor-derived bovine plasma eye serum sold through veterinary distributors to clinics for treating animal ocular surface conditions.

What SeroRepair does

SeroRepair is a privately-held veterinary biotechnology company headquartered in Kaysville, Utah (590 N. Kays Drive, Unit 110), that develops biologic products aimed at simplifying ocular care for veterinary clinics, patients, and pet owners. The company's sole commercial product, SeroLube, is a frozen, donor-derived, blood plasma-based eye serum manufactured from bovine plasma using a controlled process designed for consistency and safety. Unlike conventional autologous eye serum therapy — which requires drawing blood from the patient, processing the sample in-clinic, and decanting into dropper bottles over a 40-50 minute workflow — SeroLube is delivered as a sterile, ready-to-dispense dropper that can be stored in the clinic freezer and dispensed to the patient immediately. The product is positioned for use in corneal ulcers, indolent ulcers, corneal trauma, KCS/dry eye support, post-operative ocular care, and inflammatory ocular surface conditions, and the company frames it as supporting a Fear Free veterinary care approach by eliminating patient blood draws.

The company's business model is a one-time product sale of SeroLube, distributed exclusively through veterinary pharmaceutical and supply distributors including MWI Animal Health, Midwest Veterinary Supply, Covetrus, Vetcove, PennVet, and Veterinary Health Associates (VHA). Pricing is not publicly disclosed, and orders are routed through distributor platforms and a direct order pathway on the company's website. The primary customer segment is veterinary professionals and clinics; pet and equine owners constitute a secondary end-user audience. Marketing is concentrated in digital content (website, webinars, clinical handouts, research summaries) and distributor-led promotion, with no disclosed field sales force. The company provides no public financial data — no revenue, funding history, headcount, management team, ownership structure, or regulatory certifications are disclosed in available source material, and there is no indication of patents or trademarks on file. Company website copyright is dated 2026, and the company uses "SeroLube" as a trade name.

SeroRepair firmographics

Firmographics
Name
SeroRepair
Legal name
SeroRepair
Website
https://serorepair.com
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
SeroRepair is a privately-held veterinary biotechnology company that develops SeroLube, a frozen donor-derived bovine plasma eye serum sold through veterinary distributors to clinics for treating animal ocular surface conditions.
Ownership category
akta.pro rank

SeroRepair industry classification

Industry
Product category
Veterinary Biologics
NAICS
Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAMAEAN
Medicated Feed Additives & Premixes (Veterinary Pharmaceuticals)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics

Keywords

  • Veterinary eye serum
  • Plasma-based therapy
  • Animal ocular care
  • Veterinary biologics
  • Ophthalmic treatment products

Where SeroRepair is headquartered

Location

Headquarters

HQ city
Kaysville
HQ country
United States
HQ region
North America

Offices1 record

Markets served

SeroRepair business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Technology or R&D, Personnel, Marketing or Sales

Revenue model

  1. SeroLube Product Sales: Sale of frozen plasma eye serum products to veterinary clinics and pet owners through distributor partnerships.

Go-to-market motion1 record

Distribution channels6 records

Marketing channels3 records

SeroRepair product offering

Product offering

Core offering

SeroRepair manufactures and sells SeroLube, a frozen, donor-derived, blood plasma-based eye serum for veterinary use. The product is made from bovine plasma using a controlled manufacturing process and is packaged in sterile, ready-to-dispense dropper bottles that veterinary clinics can store in a freezer and dispense immediately to patients. It eliminates the traditional 40-50 minute in-clinic blood draw and serum processing workflow required for conventional autologous eye serum therapy.

Product overview

SeroRepair is a veterinary-focused biologic company that develops practical solutions to simplify eye care for clinics, patients, and pet owners. Their product portfolio consists of a single core offering: SeroLube, a frozen, donor-derived blood plasma-based eye serum. Unlike traditional eye serum therapy that requires in-clinic blood drawing and processing, SeroLube comes ready-to-dispense in sterile dropper bottles that can be stored in the clinic freezer and sent home with patients immediately. The product is made from bovine (cow) plasma using a controlled process designed for consistency and safety.

Differentiator

Problem solved

Functional benefit

Products and services

  • SeroLube A frozen, donor-derived, blood plasma-based eye serum for veterinary use, manufactured from bovine plasma via a controlled process. Packaged in sterile, ready-to-dispense dropper bottles that can be stored in a clinic freezer and sent home with the patient immediately. Provides serum-based biologic support for animal eyes, including tear-like proteins, growth factors, and anti-inflammatory mediators, to support epithelial health, surface hydration, and corneal comfort in conditions such as corneal ulcers, indolent ulcers, corneal trauma, KCS/dry eye, post-operative care, and inflammatory ocular surface conditions. Intended for use under the direction of a veterinarian as part of an appropriate treatment plan.

Quantifiable outcome

  • Replaces 40-50 minute eye appointment process with ready-to-use dropper dispensing

Companies that use SeroRepair

Customer profile

Segments2 records

Ideal customer profiles1 record

SeroRepair technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

SeroRepair partnerships and signals

Strategic signal

Partnerships

Six partnerships are on record, tiered core and minor.

  • MWI Animal HealthcoreChannel Partner/ Reseller/ DistributorMajor veterinary distributor offering SeroLube through their platform for ordering and distribution to veterinary clinics.
  • Midwest Veterinary SupplycoreChannel Partner/ Reseller/ DistributorRegional veterinary supply distributor providing access to SeroLube for veterinary practices in their distribution network.
  • CovetruscoreChannel Partner/ Reseller/ DistributorGlobal animal health company distributing SeroLube as part of their veterinary pharmaceutical and supply portfolio.
  • VetcoveminorChannel Partner/ Reseller/ DistributorVeterinary marketplace platform enabling veterinary practices to order SeroLube from multiple distributors.
  • PennVetminorChannel Partner/ Reseller/ DistributorUniversity-affiliated veterinary supplier distributing SeroLube, potentially serving academic veterinary hospitals.
  • Veterinary Health Associates (VHA)minorChannel Partner/ Reseller/ DistributorVeterinary buying group providing member clinics access to SeroLube at negotiated pricing through group purchasing.

Recent moves1 record

Expansion highlights4 records

SeroRepair competitors and assessment

Company assessment

Broad incumbents

  • Zoetis: Zoetis is the world's largest animal health company with a broad portfolio of companion animal pharmaceuticals and biologics. It is a broad incumbent because it sells competing ocular therapeutics alongside vaccines, parasiticides, and other biologics through the same major veterinary distributors SeroRepair relies on.
  • Ceva Animal Health: Ceva is a global animal health company with a sizable companion animal portfolio including ophthalmology products. It is a broad incumbent because it competes for veterinary shelf space and prescribing across multiple species and therapeutic categories rather than specializing in ocular biologics.
  • Dechra Pharmaceuticals: Dechra is a global specialty veterinary pharmaceuticals company with a meaningful ophthalmology portfolio and broad companion animal distribution. It is a broad incumbent because it competes for the same veterinary prescribing decisions but operates across many therapeutic categories beyond ocular biologics.
  • Virbac: Virbac is a global animal health company with a dedicated companion animal and ophthalmology presence. It is a broad incumbent because it offers competing ocular therapeutics as part of a broader portfolio and reaches US veterinary clinics through the same major distribution partners as SeroRepair.
  • Vetoquinol: Vetoquinol is an established global animal health pharmaceutical company selling through veterinary distribution. It is a broad incumbent because it competes in veterinary ocular therapeutics as part of a broader species and therapeutic portfolio served by the same veterinary wholesalers that carry SeroLube.
  • Elanco Animal Health (Remend): Elanco is a top-tier global animal health company whose Remend corneal repair gel is a directly competing veterinary ocular surface product. It is a broad incumbent because it sells the competing eye care product alongside a much larger pharmaceutical and biologic portfolio across companion animal and livestock markets.

Direct peers

  • Aventix (Optixcare): Aventix markets Optixcare and related ocular lubricants and tear-stimulating drops for companion animals. It is a direct peer because both companies provide ready-to-use ocular surface support products sold through veterinary channels as alternatives to in-clinic compounded or processed preparations.
  • Sentrx Animal Care: Sentrx develops and markets cross-linked hyaluronic acid-based eye care products (bioHAnce) for veterinary use. It is a direct peer because both companies sell biologic-style ocular surface therapeutics through veterinary distribution channels to clinics treating companion animal eye conditions.
  • Dômes Pharma (TVM): Dômes Pharma's TVM division is a European veterinary ophthalmology specialist with a broad line of ocular therapeutics. It is a direct peer because it competes in the same veterinary eye care prescribing space and addresses similar ocular surface conditions in companion animals.
  • I-MED Animal Health: I-MED Animal Health is a specialty veterinary ophthalmology company that sells diagnostic and therapeutic eye care products to veterinarians. It is a direct peer because both companies focus exclusively on veterinary ocular therapeutics sold through veterinary professional channels.

Market position

Weaknesses5 records

Competitive moat2 records

Key risks1 record

Key highlights1 record

Customer concentration

SeroRepair social profiles

Digital presence

SeroRepair financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SeroRepair leadership team

Management profile

Number of profiles

SeroRepair funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SeroRepair M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SeroRepair

What does SeroRepair do?

SeroRepair manufactures and sells SeroLube, a frozen, donor-derived, blood plasma-based eye serum for veterinary use. The product is made from bovine plasma using a controlled manufacturing process and is packaged in sterile, ready-to-dispense dropper bottles that veterinary clinics can store in a freezer and dispense immediately to patients. It eliminates the traditional 40-50 minute in-clinic blood draw and serum processing workflow required for conventional autologous eye serum therapy.

Is SeroRepair a public or private company?

SeroRepair is a private company. It is classified as unknown and is currently operating.

When was SeroRepair founded?

SeroRepair was founded in -1. It employs 1 to 10 people.

Where is SeroRepair based?

SeroRepair is headquartered in Kaysville, United States, in the North America region.

How does SeroRepair make money?

One revenue line is on record: seroLube Product Sales.

Who are SeroRepair's main competitors?

Broad incumbents on record are Zoetis, Ceva Animal Health, Dechra Pharmaceuticals, Virbac, Vetoquinol and Elanco Animal Health (Remend). Direct peers are Aventix (Optixcare), Sentrx Animal Care, Dômes Pharma (TVM) and I-MED Animal Health.

Does SeroRepair have an API?

No public API is recorded for SeroRepair.

What industry is SeroRepair in?

SeroRepair's product category is Veterinary Biologics. Its primary akta.pro industry code is HLAMAEAN, Medicated Feed Additives & Premixes (Veterinary Pharmaceuticals). Its NAICS code is 325414 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals